v3.26.1
Segment Reporting - Summary of Significant Segment Expenses (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Segment Reporting Information [Line Items]    
Research and development expenses $ (27,960) $ (23,343)
General and Administrative [1] (6,906) (5,692)
Other Segment Items [2] 1,182 1,552
Net loss (33,685) (27,483)
Clinical, Preclinical, and R&D Operations    
Segment Reporting Information [Line Items]    
Research and development expenses [1] (19,367) (16,386)
Chemistry, Manufacturing and Controls    
Segment Reporting Information [Line Items]    
Research and development expenses [1] $ (8,594) $ (6,957)
[1] Includes depreciation expense directly allocated to respective activities.
[2] Other segment items primarily include interest and accretion income, realized gains and losses, and income taxes.